1-4 of 4
Douglas S. Tyler
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Sorafenib, a Multikinase Inhibitor, Enhances the Response of Melanoma to Regional Chemotherapy

Christina K. Augustine, Hiroaki Toshimitsu, Sin-Ho Jung, Patricia A. Zipfel, Jin S. Yoo, Yasunori Yoshimoto, M. Angelica Selim, James Burchette, Georgia M. Beasley, Nicole McMahon, James Padussis, Scott K. Pruitt, Francis Ali-Osman, Douglas S. Tyler
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (7): 2090–2101.
https://doi.org/10.1158/1535-7163.MCT-10-0073
Published: 07 July 2010
View article titled, Sorafenib, a Multikinase Inhibitor, Enhances the Response of Melanoma to Regional Chemotherapy
Open the PDF for Sorafenib, a Multikinase Inhibitor, Enhances the Response of Melanoma to Regional Chemotherapy in another window
Includes: Supplementary data
Journal Articles

Gene Expression Signatures as a Guide to Treatment Strategies for In-Transit Metastatic Melanoma

Christina K. Augustine, Sin-Ho Jung, Insuk Sohn, Jin Soo Yoo, Yasunori Yoshimoto, John A. Olson, Jr., Henry S. Friedman, Francis Ali-Osman, Douglas S. Tyler
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (4): 779–790.
https://doi.org/10.1158/1535-7163.MCT-09-0764
Published: 07 April 2010
View article titled, Gene Expression Signatures as a Guide to Treatment Strategies for In-Transit Metastatic Melanoma
Open the PDF for Gene Expression Signatures as a Guide to Treatment Strategies for In-Transit Metastatic Melanoma in another window
Includes: Supplementary data
Journal Articles

Defining regional infusion treatment strategies for extremity melanoma: comparative analysis of melphalan and temozolomide as regional chemotherapeutic agents

Yasunori Yoshimoto, Christina K. Augustine, Jin S. Yoo, Patricia A. Zipfel, M. Angelica Selim, Scott K. Pruitt, Henry S. Friedman, Francis Ali-Osman, Douglas S. Tyler
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (5): 1492–1500.
https://doi.org/10.1158/1535-7163.MCT-06-0718
Published: 18 May 2007
View article titled, Defining regional infusion treatment strategies for extremity melanoma: comparative analysis of melphalan and temozolomide as regional chemotherapeutic agents
Open the PDF for Defining regional infusion treatment strategies for extremity melanoma: comparative analysis of melphalan and temozolomide as regional chemotherapeutic agents in another window
Journal Articles

Modulation of chemotherapy resistance in regional therapy: a novel therapeutic approach to advanced extremity melanoma using intra-arterial temozolomide in combination with systemic O6-benzylguanine

Tomio Ueno, Sae Hee Ko, Elizabeth Grubbs, Yasunori Yoshimoto, Christi Augustine, Zeinab Abdel-Wahab, Tsung-Yen Cheng, Omar I. Abdel-Wahab, Scott K. Pruitt, Henry S. Friedman, Douglas S. Tyler
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (3): 732–738.
https://doi.org/10.1158/1535-7163.MCT-05-0098
Published: 16 March 2006
View article titled, Modulation of chemotherapy resistance in regional therapy: a novel therapeutic approach to advanced extremity melanoma using intra-arterial temozolomide in combination with systemic <em>O</em><sup>6</sup>-benzylguanine
Open the PDF for Modulation of chemotherapy resistance in regional therapy: a novel therapeutic approach to advanced extremity melanoma using intra-arterial temozolomide in combination with systemic <em>O</em><sup>6</sup>-benzylguanine in another window